title: [Survey findings about elucidating the actual condition of asthma treatment in emergency settings. ∼Activity report of "zero asthma death committee in Hyogo"∼].
abstract: OBJECTIVE
  To elucidate the actual condition of asthma treatment in emergency settings.
  
  
  METHODS
  A questionnaire survey on the situation of emergency care was conducted on 175 medical institutions providing either secondary or tertiary emergency care in Hyogo Prefecture during a 1-year period starting in April 2010. Data were investigated for each secondary medical region.
  
  
  RESULTS
  Responses were obtained from 143 medical institutions (response rate, 81.7%). Steroid injection, aminophylline injection, and short-acting beta-agonists (SABA) were selected as drugs in emergency room treatment in many districts (in order, means of 86.7%, 79.5%, 72.3%). Concerning drugs prescribed on leaving hospital, transdermal β2 stimulator and SABA were selected in >50% of districts. Prescriptions for long-term management varied among districts, as follows: inhaled corticosteroids (ICS), mean of 37.3% (0-66.7%); ICS/long-acting β-agonists (LABA), 27.9% (16.7-66.7%); and leukotriene receptor antagonist (LTRA), 20.5% (0-50.0%)
  
  
  CONCLUSIONS
  These findings suggest that asthma treatment in emergency settings varies by facility and region.
authors.affiliation: Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Suya
authors.initials: S
authors.lastname: Hori
authors.affiliation: Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; Facilitator of "Zero Asthma Death Committee of Hyogo"
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Nishimura
authors.affiliation: Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Haruko
authors.initials: H
authors.lastname: Shinke
authors.affiliation: Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Nobuko
authors.initials: N
authors.lastname: Hazeki
authors.affiliation: Division of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Kobayashi
authors.affiliation: Facilitator of "Zero Asthma Death Committee of Hyogo"; Kaibara Red Cross Hospital.
authors.forename: Satoru
authors.initials: S
authors.lastname: Katayama
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D026683:Advisory Committees / Q000458:organization & administration*; D000368:Aged; D000369:Aged, 80 and over; D000628:Aminophylline / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality*; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004358:Drug Therapy; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007223:Infant; D007564:Japan / Q000453:epidemiology; D020024:Leukotriene Antagonists / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011314:Preventive Health Services / Q000458:organization & administration*; D011795:Surveys and Questionnaires
chemical_list: D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists; D000628:Aminophylline